These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 22959553)

  • 1. Thrombolytic therapy for submassive pulmonary embolism.
    Lankeit M; Konstantinides S
    Best Pract Res Clin Haematol; 2012 Sep; 25(3):379-89. PubMed ID: 22959553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial.
    Steering Committee
    Am Heart J; 2012 Jan; 163(1):33-38.e1. PubMed ID: 22172434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should thrombolytic therapy be used in patients with pulmonary embolism?
    Konstantinides S
    Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for pulmonary embolism.
    Katchan BM
    Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submassive pulmonary embolism.
    Busse LW; Vourlekis JS
    Crit Care Clin; 2014 Jul; 30(3):447-73. PubMed ID: 24996605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrinolysis in pulmonary embolism].
    Thabut G; Jebrak G
    Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pulmonary embolism advances in treatment.
    Gupta S; Gupta BM
    J Assoc Physicians India; 2008 Mar; 56():185-91. PubMed ID: 18697636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massive pulmonary embolism: what level of aggression?
    Konstantinides SV
    Semin Respir Crit Care Med; 2008 Feb; 29(1):47-55. PubMed ID: 18302086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
    Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
    Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin.
    Fasullo S; Scalzo S; Maringhini G; Ganci F; Cannizzaro S; Basile I; Cangemi D; Terrazzino G; Parrinello G; Sarullo FM; Baglini R; Paterna S; Di Pasquale P
    Am J Med Sci; 2011 Jan; 341(1):33-9. PubMed ID: 20890176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis in submassive pulmonary embolism, prudent or puerile?
    Rehman A; Yousaf S; Chugh A
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23354859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
    Konstantinides S; Geibel A; Heusel G; Heinrich F; Kasper W;
    N Engl J Med; 2002 Oct; 347(15):1143-50. PubMed ID: 12374874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary pulmonary embolism thrombolysis.
    Goldhaber SZ
    Chest; 1995 Jan; 107(1 Suppl):45S-51S. PubMed ID: 7813329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical audit of thrombolytic therapy in patients with normotensive pulmonary embolism and intermediate risk.
    Nobre C; Mesquita D; Thomas B; Ponte T; Santos L; Tavares J
    Acute Card Care; 2014 Jun; 16(2):63-6. PubMed ID: 24617753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of massive pulmonary embolism with prolonged catheter-directed thrombolysis.
    Kelly P; Carroll N; Grant C; Barrett C; Kocka V
    Heart Vessels; 2006 Mar; 21(2):124-6. PubMed ID: 16550314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary embolism thrombolysis: Do we need another agent?
    Goldhaber SZ
    Am Heart J; 1999 Jul; 138(1 Pt 1):1-2. PubMed ID: 10385751
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis in Pulmonary Embolism: An Evidence-Based Approach to Treating Life-Threatening Pulmonary Emboli.
    Kaplovitch E; Shaw JR; Douketis J
    Crit Care Clin; 2020 Jul; 36(3):465-480. PubMed ID: 32473692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.
    Becattini C; Agnelli G; Salvi A; Grifoni S; Pancaldi LG; Enea I; Balsemin F; Campanini M; Ghirarduzzi A; Casazza F;
    Thromb Res; 2010 Mar; 125(3):e82-6. PubMed ID: 19833379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Thrombolysis Therapy is Associated With Improved Outcomes Among Patients With Acute Pulmonary Embolism and Respiratory Failure.
    Koslow M; Epstein Shochet G; Fenadka F; Neuman Y; Osadchy A; Shitrit D
    Am J Med Sci; 2020 Aug; 360(2):129-136. PubMed ID: 32466857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.